UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Survival of Del17p CLL Depends on Genomic Complexity and Somatic Mutation

Clinical cancer research, 2017-02, Vol.23 (3), p.735-745

2017

Volltextzugriff (PDF)

SF3B1 and Other Novel Cancer Genes in Chronic Lymphocytic Leukemia

The New England journal of medicine, 2011-12, Vol.365 (26), p.2497-2506

2011

Volltextzugriff (PDF)

Dual Signaling of MyD88 and TRIF Is Critical for Maximal TLR4-Induced Dendritic Cell Maturation

The Journal of immunology (1950), 2008-08, Vol.181 (3), p.1849-1858

2008

Volltextzugriff (PDF)

Aging Impairs IFN Regulatory Factor 7 Up-Regulation in Plasmacytoid Dendritic Cells during TLR9 Activation

The Journal of immunology (1950), 2008-11, Vol.181 (10), p.6747-6756

2008

Volltextzugriff (PDF)

Critical role of the Toll-like receptor signal adaptor protein MyD88 in acute allograft rejection

The Journal of clinical investigation, 2003-05, Vol.111 (10), p.1571-1578

2003

Volltextzugriff (PDF)

MYD88 L265P mutations identify a prognostic gene expression signature and a pathway for targeted inhibition in CLL

British journal of haematology, 2019-03, Vol.184 (6), p.925-936

2019

Volltextzugriff (PDF)

TH1 Immune Responses to Fully MHC Mismatched Allografts are Diminished in the Absence of MyD88, a Toll‐Like Receptor Signal Adaptor Protein

American journal of transplantation, 2004-09, Vol.4 (9), p.1429-1439

2004

Volltextzugriff (PDF)

Absence of Innate MyD88 Signaling Promotes Inducible Allograft Acceptance

Journal of Immunology, 2006-10, Vol.177 (8), p.5307-5316

2006

Volltextzugriff (PDF)

Aging impairs recipient T cell intrinsic and extrinsic factors in response to transplantation

PloS one, 2009, Vol.4 (1), p.e4097-e4097

2009

Volltextzugriff (PDF)

Toll-like receptors and their role in transplantation

Frontiers in bioscience, 2007-05, Vol.12 (8-12), p.4221

2007

Volltextzugriff (PDF)

A phase I study of escalated dose subcutaneous alemtuzumab given weekly with rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma

Haematologica (Roma), 2013-06, Vol.98 (6), p.964-970

2013

Volltextzugriff (PDF)

Acute allograft rejection occurs independently of inducible heat shock protein-70

Transplantation, 2007-06, Vol.83 (11), p.1513-1517

2007

Volltextzugriff (PDF)

Targeting transcription regulation in cancer with a covalent CDK7 inhibitor

Nature (London), 2014-07, Vol.511 (7511), p.616-620

2014

Volltextzugriff (PDF)

Evolution and Impact of Subclonal Mutations in Chronic Lymphocytic Leukemia

Cell, 2013-02, Vol.152 (4), p.714-726

2013

Volltextzugriff (PDF)

Direct Antigen Presentation by a Xenograft Induces Immunity Independently of Secondary Lymphoid Organs

The Journal of immunology (1950), 2004-10, Vol.173 (7), p.4377-4386

2004

Volltextzugriff (PDF)

Toll-like receptors and allograft rejection

American journal of respiratory and critical care medicine, 2004-04, Vol.169 (8), p.971; author reply 971-972

2004

Volltextzugriff (PDF)

Murine [corrected] myeloid dendritic cell-dependent toll-like receptor immunity is preserved with aging

Aging cell, 2006-12, Vol.5 (6), p.473-486

2006

Volltextzugriff (PDF)

Integrative Genomic Analysis Implicates Gain of PIK3CA at 3q26 and MYC at 8q24 in Chronic Lymphocytic Leukemia

Clinical cancer research, 2012-07, Vol.18 (14), p.3791-3802

2012

Volltextzugriff (PDF)

MYD 88 L265P mutations identify a prognostic gene expression signature and a pathway for targeted inhibition in CLL

British journal of haematology, 2019-03, Vol.184 (6), p.925-936

2019

Volltextzugriff (PDF)

Obatoclax in combination with fludarabine and rituximab is well-tolerated and shows promising clinical activity in relapsed chronic lymphocytic leukemia

Leukemia & lymphoma, 2015-12, Vol.56 (12), p.3336-3342

2015

Volltextzugriff (PDF)

Abstract LB-A20: True small molecule STING agonist generates systemic and potent anti-tumor immunity required for effective cancer immunotherapy

Molecular cancer therapeutics, 2019-12, Vol.18 (12_Supplement), p.LB-A20-LB-A20

2019

Volltextzugriff (PDF)

Rare Germline Variant in NFATC4 Associated with Familial Chronic Lymphocytic Leukemia

Blood, 2017-12, Vol.130, p.2993-2993

2017

Volltextzugriff (PDF)

Nurine myeloid dendritic cell‐dependent toll‐like receptor immunity is preserved with aging

Aging cell, 2006-12, Vol.5 (6), p.473-486

2006

Volltextzugriff (PDF)

Aging Augments IL‐17 T‐Cell Alloimmune Responses

American journal of transplantation, 2009-01, Vol.9 (1), p.54-63

2009

Volltextzugriff (PDF)

Discovery of a Series of 5,11-Dihydro‑6H‑benzo[e]pyrimido[5,4‑b][1,4]diazepin-6-ones as Selective PI3K-δ/γ Inhibitors

ACS medicinal chemistry letters, 2016-10, Vol.7 (10), p.908-912

2016

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(40)

Publikationsform

Artikel
(43)
Berichte
(1)

Sprache

Englisch
(44)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

Science & Technology
(21)
Life Sciences & Biomedicine
(19)
Animals
(12)
Humans
(11)
Mice
(10)
Dendritic Cells - Immunology
(8)
Female
(6)
Graft Rejection - Immunology
(6)
Immunology
(6)
Male
(6)
Chronic Lymphocytic Leukemia
(5)
Leukemia, Lymphocytic, Chronic, B-Cell - Drug Therapy
(5)
Leukemia, Lymphocytic, Chronic, B-Cell - Genetics
(5)
Middle Aged
(5)
Mutation
(5)
Skin Transplantation - Immunology
(5)
Transplantation
(5)
Adult
(4)
Aged
(4)
Aging - Immunology
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Survival of Del17p CLL Depends on Genomic Complexity and Somatic Mutation

SF3B1 and Other Novel Cancer Genes in Chronic Lymphocytic Leukemia

Dual Signaling of MyD88 and TRIF Is Critical for Maximal TLR4-Induced Dendritic Cell Maturation

Aging Impairs IFN Regulatory Factor 7 Up-Regulation in Plasmacytoid Dendritic Cells during TLR9 Activation

Critical role of the Toll-like receptor signal adaptor protein MyD88 in acute allograft rejection

MYD88 L265P mutations identify a prognostic gene expression signature and a pathway for targeted inhibition in CLL

TH1 Immune Responses to Fully MHC Mismatched Allografts are Diminished in the Absence of MyD88, a Toll‐Like Receptor Signal Adaptor Protein

Absence of Innate MyD88 Signaling Promotes Inducible Allograft Acceptance

Aging impairs recipient T cell intrinsic and extrinsic factors in response to transplantation

Toll-like receptors and their role in transplantation

A phase I study of escalated dose subcutaneous alemtuzumab given weekly with rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma

Acute allograft rejection occurs independently of inducible heat shock protein-70

Targeting transcription regulation in cancer with a covalent CDK7 inhibitor

Evolution and Impact of Subclonal Mutations in Chronic Lymphocytic Leukemia

Direct Antigen Presentation by a Xenograft Induces Immunity Independently of Secondary Lymphoid Organs

Toll-like receptors and allograft rejection

Murine [corrected] myeloid dendritic cell-dependent toll-like receptor immunity is preserved with aging

Integrative Genomic Analysis Implicates Gain of PIK3CA at 3q26 and MYC at 8q24 in Chronic Lymphocytic Leukemia

MYD 88 L265P mutations identify a prognostic gene expression signature and a pathway for targeted inhibition in CLL

Obatoclax in combination with fludarabine and rituximab is well-tolerated and shows promising clinical activity in relapsed chronic lymphocytic leukemia

Abstract LB-A20: True small molecule STING agonist generates systemic and potent anti-tumor immunity required for effective cancer immunotherapy

Rare Germline Variant in NFATC4 Associated with Familial Chronic Lymphocytic Leukemia

Nurine myeloid dendritic cell‐dependent toll‐like receptor immunity is preserved with aging

Aging Augments IL‐17 T‐Cell Alloimmune Responses

Discovery of a Series of 5,11-Dihydro‑6H‑benzo[e]pyrimido[5,4‑b][1,4]diazepin-6-ones as Selective PI3K-δ/γ Inhibitors

Suchergebnisse filtern